BBI NASDAQ
Brickell Biotech, Inc.
1W: -4.1%
1M: -42.3%
3M: +1578.6%
1Y: +186.6%
3Y: -44.0%
$2.35
Last traded 2022-09-07 — delisted
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Revenue Segmentation
By Product / Service
Revenue by Segment (5-Year Trend)
Income Trends
Revenue
$404K
-77.8% ▼
5Y CAGR: -51.2%
Gross Profit
$404K
-77.8% ▼
5Y CAGR: -45.3%
Operating Income
-$39M
-87.9% ▼
Net Income
-$40M
-89.1% ▼
EPS (Diluted)
$-22.16
+42.3% ▲
EBITDA
-$40M
-91.9% ▼
Profit Margins
Year-over-Year Growth
View Full Income Statement
| Line Item | FY2017 | FY2018 | FY2019 | FY2020 | FY2021 |
|---|---|---|---|---|---|
| Revenue | $14M | $2M | $8M | $2M | $404K |
| YoY Growth | -4.9% | -88.3% | +388.1% | -77.0% | -77.8% |
| Cost of Revenue | $6M | $1M | $0 | $0 | $0 |
| Gross Profit | $7M | $186K | $8M | $2M | $404K |
| Gross Margin | 53.1% | 11.5% | 100.0% | 100.0% | 100.0% |
| R&D Expenses | $14M | $12M | $20M | $11M | $28M |
| SG&A Expenses | $19M | $10M | $12M | $12M | $12M |
| Operating Expenses | $27M | $21M | $32M | $23M | $41M |
| Operating Income | -$13M | -$20M | -$24M | -$21M | -$39M |
| Operating Margin | -96.9% | -1211.2% | -309.1% | -1151.3% | -9753.7% |
| Interest Expense | $0 | $1M | $2M | $0 | $69K |
| Income Before Tax | -$13M | -$16M | -$24M | -$21M | -$39M |
| Tax Expense | $0 | $0 | $0 | $0 | $69K |
| Net Income | -$13M | -$16M | -$24M | -$21M | -$40M |
| Net Margin | -93.8% | -1002.1% | -301.6% | -1147.8% | -9787.9% |
| EPS (Diluted) | $-316.76 | $-234.41 | $-355.43 | $-38.39 | $-22.16 |
| EBITDA | -$13M | -$20M | -$22M | -$21M | -$40M |
| Shares Outstanding | 40914 | 69339 | 67178 | 544759 | 2M |